Ultragenyx Pharmaceutical Заявленная компания

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases. читать еще

СОТРУДНИКИ УЧАСТНИКИ: 20

ИТОГО РЕЙТИНГИ: 230

СЕО: Emil Kakkis

HR or Marketing? Claim Your Free Employer Account

Emil Kakkis Ultragenyx Pharmaceutical CEO Rating

Ultragenyx Pharmaceutical's CEO, Emil Kakkis, has 18 employee ratings and a score of 86/100, placing them in the Top 5% of similar size companies on Comparably with 501-1000 сотрудников and Top 5% of other companies in San Francisco. When breaking the CEO score down by factors such as department, gender, and ethnicity, we see that males at Ultragenyx Pharmaceutical rate Emil Kakkis higher than females, giving the CEO a score of 98/100.

Last updated months ago.

Where This Score Ranks Ultragenyx Pharmaceutical's CEO Rating

TOP
5%
In the Top 5% of 1832 Similar Sized Companies on Comparably
TOP
5%
In the Top 5% of 932 Nearby Companies in San Francisco
1st
1st place versus 4 competitors rated on Comparably

Feb

Apr

Sep

Jan

A+86 / 100

Jan

Ultragenyx Pharmaceutical CEO Emil Kakkis Bio

Emil Kakkis serves as the CEO / President of Ultragenyx Pharmaceutical.

Who Ranks Ultragenyx Pharmaceutical's CEO Rating the Highest?

Ethnicity - Caucasian 100/100

Gender - Male 98/100

Experience - 3 to 6 Years 97/100

Who Ranks Ultragenyx Pharmaceutical's CEO Rating the Lowest?

Experience - Over 10 Years 83/100

Gender - Female 83/100

Ultragenyx Pharmaceutical CEO Emil Kakkis At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Ultragenyx Pharmaceutical.

Based on 18 ratings, Emil Kakkis ranks right above Illumina's CEO, Francis deSouza.

Ultragenyx Pharmaceutical's CEO is highly regarded by Caucasian employees, Male employees, and employees with 3 to 6 Years experience. However, employees with Over 10 Years experience and Female employees have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.